53310 Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices 

Dated: August 20, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–21503 Filed 8–30–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day 10–10GP] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. 

Alternatively, to obtain a copy of the 

data collection plans and instrument, 

call 404–639–5960 and send comments 

to Maryam I. Daneshvar, CDC Reports 

Clearance Officer, 1600 Clifton Road 

NE., MS–D74, Atlanta, Georgia 30333; 

comments may also be sent by e-mail to 

omb@cdc.gov. 

Comments are invited on (a) whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have a 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarify of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of information technology. Written 

comments should be received within 60 

days of this notice. 

Proposed Project 

Clostridium difficile Infection (CDI) 

Surveillance—New—National Center for 

Emerging and Zoonotic Infectious 

Diseases, (NCEZID), Centers for Disease 

Control and Prevention, (CDC). 

Background and Brief Description 

Steady increases in the rate and 

severity of Clostridium difficile 

infection (CDI) indicate a clear need to 

conduct longitudinal assessments of the 

impact of CDI in the United States. C. 

difficile is an anaerobic, spore-forming, 

gram positive bacillus that produces two 

pathogenic toxins: A and B. CDI ranges 

in severity from mild diarrhea to 

fulminant colitis and death. 

Transmission of C. difficile occurs 

primarily in healthcare facilities, where 

environmental contamination by C. 

difficile spores and exposure to 

antimicrobial drugs are common. No 

longer limited to healthcare 

environments, community-associated 

CDI is the focus of increasing attention. 

Recently, several cases of serious CDI 

have been reported in what have been 

considered low-risk populations, 

including healthy persons living in the 

community and peri-partum women. 

The surveillance population will 

consist of persons residing in the 

catchment area of the participating 

Emerging Infections Program (EIP) sites. 

This surveillance poses no more than 

minimal risk to the study participants as 

there will be no interventions or 

modifications to the care study 

participants receive. EIP surveillance 

personnel will perform active case 

finding from laboratory reports of stool 

specimens testing positive for C. 

difficile toxin and abstract data on cases 

using a standardized case report form. 

For a subset of cases (e.g., communityassociated C. difficile cases) sites will 

administer a health interview. Remnant 

stool specimens from cases testing 

positive for C. difficile toxin will be 

submitted to reference laboratories for 

culturing, and isolates will be sent to 

CDC for confirmation and molecular 

typing. Outcomes of this surveillance 

project will include the populationbased incidence of community- and 

healthcare-associated CDI, and a 

description of the molecular 

characteristics of C. difficile strains and 

the epidemiology of this infection 

among the population under 

surveillance. 

For this proposed data collection, 

there is no cost to respondents other 

than their time. An estimated total of 

8,750 CDI Surveillance Case Report 

Forms (CRFs) will be completed during 

a one-year study period. Approximately 

4,370 cases will require a completed 

CRF taking one hour; the remaining 

4,380 cases will only require a partially 

completed CRF taking 15 minutes. An 

estimated total of 500 CDI Surveillance 

Health Interviews (HI) will need to be 

completed for the same time period. The 

estimated time to complete the HI is 45 

minutes. Therefore, the total estimated 

annualized burden for this data 

collection is 5,840 hours. 

The proposed surveillance for CDI 

through the Emerging Infections 

Program will expand CDC capacity to 

monitor incidence of C. difficile in 

community and healthcare settings as 

well as to monitor and detect 

antimicrobial resistance. This activity 

supports the HHS Action Plan for 

elimination of healthcare-associated 

infections. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Forms Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

CDI Surveillance Case Report Form—Complete ............................................ 10 437 1 4,370 

CDI Surveillance Case Report Form—Partial ................................................. 10 438 15/60 1,095 

CDI Surveillance Health Interview ................................................................... 10 50 45/60 375 

Total .......................................................................................................... 5,840 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 168 / Tuesday, August 31, 2010 / Notices 53311 

Dated: August 25, 2010. 

Carol Walker, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2010–21737 Filed 8–30–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30-Day–10–0798] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Health Marketing (OMB No. 0920– 

0798, exp. 01/31/2011)—Extension— 

Office of the Associate Director for 

Communication (OADC), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Today, CDC is globally recognized for 

conducting research and investigations 

and for its action oriented approach. 

CDC applies research and findings to 

improve people’s daily lives and 

responds to health emergencies— 

something that distinguishes CDC from 

its peer agencies. 

CDC is committed to achieving true 

improvements in people’s health. To do 

this, the agency is defining specific 

health protection goals to prioritize and 

focus its work and investments and 

measure progress. 

It is imperative that CDC provide 

high-quality timely information and 

programs in the most effective ways to 

help people, families, and communities 

protect their health and safety. Through 

continuous consumer feedback, 

prevention research, and public health 

information technology, we identify and 

evaluate health needs and interests, 

translate science into actions to meet 

those needs, and engage the public in 

the excitement of discovery and the 

progress being made to improve the 

health of the Nation. In our outreach to 

partners, we build relationships that 

model shared learning, mutual trust, 

and diversity in points of view and 

sectors of society. 

OADC is requesting a 3-year extension 

of OMB 0920–0798, Health Marketing, 

to provide feedback on the 

development, implementation and 

satisfaction regarding public health 

services, products, communication 

campaigns and information. The 

information will be collected using 

standard qualitative and quantitative 

methods such as interviews, focus 

groups, and panels, as well as 

questionnaires administered in person, 

by telephone, by mail, by e-mail, and 

online. More specific types of studies 

may include: User experience and usertesting; concept/product/package 

development testing; brand positioning/ 

identity research; customer satisfaction 

surveying; ethnography/observational 

studies; and mystery shopping. The data 

will be used to provide input to the 

development, delivery and 

communication of public health 

services and information at CDC and to 

address emerging programmatic needs. 

Every National Center and Office at 

CDC will have the opportunity to utilize 

this generic clearance. There is no cost 

to the respondents other than their time. 

The total estimated burden hours are 

11,250. 

Type of respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average burden per response 

(in hours) 

CDC Partners, Public Health Professionals, Health Care Professionals, General Public .......... 25,000 1 27/60 

Dated: August 24, 2010. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2010–21736 Filed 8–30–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30-Day–10–0736] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Human Smoking Behavior Study— 

Reinstatement with Change—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Cigarettes have been ranked as fullflavor, light or ultralight on the basis of 

machine-measured levels of smoke 

toxins (yield categories). The machinebased methods approximate human 

smoking patterns under controlled 

conditions but may not accurately 

reflect conditions of actual use, 

moreover, public health data have not 

consistently shown differences in health 

outcomes among smokers of cigarettes 

of different machine-smoked yield 

categories. 

In 2007, the Centers for Disease 

Control and Prevention (CDC) received 

OMB approval for a research study 

designed to elucidate patterns of human 

smoking behavior, quantify biomarkers 

of exposure to smoke toxins under 

conditions of actual use, and assess how 

smoking behavior modifies the 

relationship between cigarette yield 

category, biomarkers of exposure, and 

measures of cardiovascular reactivity 

(OMB No. 0920–0736, exp. 3/31/2010). 

The study was initiated collaboratively 

by the National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP) and the National 


srobinson on DSKHWCL6B1PROD with NOTICES